138 related articles for article (PubMed ID: 18818074)
1. Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.
Oslund RC; Cermak N; Verlinde CL; Gelb MH
Bioorg Med Chem Lett; 2008 Oct; 18(20):5415-9. PubMed ID: 18818074
[TBL] [Abstract][Full Text] [Related]
2. Induction of distinct sets of secretory phospholipase A(2) in rodents during inflammation.
Hamaguchi K; Kuwata H; Yoshihara K; Masuda S; Shimbara S; Oh-ishi S; Murakami M; Kudo I
Biochim Biophys Acta; 2003 Nov; 1635(1):37-47. PubMed ID: 14642775
[TBL] [Abstract][Full Text] [Related]
3. The application of rational design on phospholipase A(2) inhibitors.
Mouchlis VD; Barbayianni E; Mavromoustakos TM; Kokotos G
Curr Med Chem; 2011; 18(17):2566-82. PubMed ID: 21568891
[TBL] [Abstract][Full Text] [Related]
4. Suppression of inflammatory responses to 12-O-tetradecanoyl-phorbol-13-acetate and carrageenin by YM-26734, a selective inhibitor of extracellular group II phospholipase A2.
Miyake A; Yamamoto H; Kubota E; Hamaguchi K; Kouda A; Honda K; Kawashima H
Br J Pharmacol; 1993 Sep; 110(1):447-53. PubMed ID: 8220906
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of selective inhibitors of human group IIA secreted phospholipase A(2) and hyaluronic acid-linked inhibitor conjugates.
Oslund RC; Gelb MH
Biochemistry; 2012 Oct; 51(43):8617-26. PubMed ID: 23020658
[TBL] [Abstract][Full Text] [Related]
6. A novel approach to the design of inhibitors of human secreted phospholipase A2 based on native peptide inhibition.
Church WB; Inglis AS; Tseng A; Duell R; Lei PW; Bryant KJ; Scott KF
J Biol Chem; 2001 Aug; 276(35):33156-64. PubMed ID: 11427527
[TBL] [Abstract][Full Text] [Related]
7. Exogenous group II phospholipase A2 induces prostaglandin E2 production in mouse peritoneal macrophages.
Miyake A; Yamamoto H; Enomori T; Kawashima H
Eur J Pharmacol; 1994 Feb; 253(1-2):155-61. PubMed ID: 8013541
[TBL] [Abstract][Full Text] [Related]
8. Anthrax lethal toxin down-regulates type-IIA secreted phospholipase A(2) expression through MAPK/NF-kappaB inactivation.
Raymond B; Ravaux L; Mémet S; Wu Y; Sturny-Leclère A; Leduc D; Denoyelle C; Goossens PL; Payá M; Raymondjean M; Touqui L
Biochem Pharmacol; 2010 Apr; 79(8):1149-55. PubMed ID: 19962969
[TBL] [Abstract][Full Text] [Related]
9. A novel bacterial resistance mechanism against human group IIA-secreted phospholipase A2: role of Streptococcus pyogenes sortase A.
Movert E; Wu Y; Lambeau G; Touqui L; Areschoug T
J Immunol; 2011 Dec; 187(12):6437-46. PubMed ID: 22075700
[TBL] [Abstract][Full Text] [Related]
10. The inactivation mechanism of human group IIA phospholipase A(2) by Scalaradial.
Margarucci L; Monti MC; Chini MG; Tosco A; Riccio R; Bifulco G; Casapullo A
Chembiochem; 2012 Oct; 13(15):2259-64. PubMed ID: 23008213
[TBL] [Abstract][Full Text] [Related]
11. Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition-mediated cell death in K-ras mutant lung cancer cells.
Yu JA; Li H; Meng X; Fullerton DA; Nemenoff RA; Mitchell JD; Weyant MJ
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1479-85. PubMed ID: 23026567
[TBL] [Abstract][Full Text] [Related]
12. The atypical binding mechanism of second calcium on phospholipase A2 group IIE.
Hou S; Bai J; Chen C; Zhang X; Chang F; Cao Z; Xu T; Xie J
Biochem Biophys Res Commun; 2021 Jun; 557():267-272. PubMed ID: 33894413
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of sPLA₂-IIA prevents LPS-induced neuroinflammation by suppressing ERK1/2-cPLA₂α pathway in mice cerebral cortex.
Xiang Y; Chen L; Liu H; Liu X; Wei X; Sun B; Wang T; Zhang X
PLoS One; 2013; 8(10):e77909. PubMed ID: 24130900
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of type 2A secretory phospholipase A2 reduces death of cardiomyocytes in acute myocardial infarction.
van Dijk A; Krijnen PA; Vermond RA; Pronk A; Spreeuwenberg M; Visser FC; Berney R; Paulus WJ; Hack CE; van Milligen FJ; Niessen HW
Apoptosis; 2009 Jun; 14(6):753-63. PubMed ID: 19421861
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulations reveal structural insights into inhibitor binding modes and functionality in human Group IIA phospholipase A
Kim RR; Malde AK; Nematollahi A; Scott KF; Church WB
Proteins; 2017 May; 85(5):827-842. PubMed ID: 28056488
[TBL] [Abstract][Full Text] [Related]
16. The molecular mechanism of human group IIA phospholipase A2 inactivation by bolinaquinone.
Monti MC; Chini MG; Margarucci L; Tosco A; Riccio R; Bifulco G; Casapullo A
J Mol Recognit; 2009; 22(6):530-7. PubMed ID: 19621421
[TBL] [Abstract][Full Text] [Related]
17. A novel role of group VIB calcium-independent phospholipase A2 (iPLA2gamma) in the inducible expression of group IIA secretory PLA2 in rat fibroblastic cells.
Kuwata H; Fujimoto C; Yoda E; Shimbara S; Nakatani Y; Hara S; Murakami M; Kudo I
J Biol Chem; 2007 Jul; 282(28):20124-32. PubMed ID: 17475622
[TBL] [Abstract][Full Text] [Related]
18. Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.
Vasilakaki S; Barbayianni E; Leonis G; Papadopoulos MG; Mavromoustakos T; Gelb MH; Kokotos G
Bioorg Med Chem; 2016 Apr; 24(8):1683-95. PubMed ID: 26970660
[TBL] [Abstract][Full Text] [Related]
19. Oxidized phosphatidylcholine stimulates activity of secretory phospholipase A2 group IIA and abolishes sphingomyelin-induced inhibition of the enzyme.
Korotaeva AA; Samoilova EV; Piksina GF; Prokazova NV
Prostaglandins Other Lipid Mediat; 2010 Feb; 91(1-2):38-41. PubMed ID: 20044023
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the complete set of mammalian secreted phospholipases A(2) by indole analogues: a structure-guided study.
Smart BP; Pan YH; Weeks AK; Bollinger JG; Bahnson BJ; Gelb MH
Bioorg Med Chem; 2004 Apr; 12(7):1737-49. PubMed ID: 15028265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
